4P-Pharma: CORRECTING and REPLACING: 4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis
4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis 4Moving Biotech, a biotechnology company and subsidiary of 4P-Pharma, focusing on the development of
France General Francis Berenbaum Kostenloser Wertpapierhandel Emmanuel Dadj Communication Service Sorbonne University
Source: finanznachrichten.de